Lucira Health Inc
NASDAQ:LHDX
Lucira Health Inc
Interest Income Expense
Lucira Health Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
L
|
Lucira Health Inc
NASDAQ:LHDX
|
Interest Income Expense
-$270k
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$549m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-5%
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
$97m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Lucira Health Inc's Interest Income Expense?
Interest Income Expense
-270k
USD
Based on the financial report for Dec 31, 2021, Lucira Health Inc's Interest Income Expense amounts to -270k USD.
What is Lucira Health Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
10%
Over the last year, the Interest Income Expense growth was 96%. The average annual Interest Income Expense growth rates for Lucira Health Inc have been 10% over the past three years .